Onkure Therapeutics, Inc. · NASDAQ:OKUR
Prosight Management, LP's stake in Onkure Therapeutics, Inc. fell to 2.40% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 10, 2026
Prosight Management, LP's stake in Onkure Therapeutics, Inc. fell to 2.40%, 978,992 shares, as a passive investor on Jun 30, 2026. Filed Aug 10, 2026 (Schedule 13G/A).
- Stake
- 2.40%
- Shares
- 978,992
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Prosight Management, LP | 2.40% | 978,992 |
| Prosight Fund, LP | 0.10% | 45,771 |
| Prosight Plus Fund, LP | 0.50% | 219,725 |
| Prosight Partners, LLC | 2.40% | 978,992 |
| W. Lawrence Hawkins | 2.40% | 978,992 |
Source
Related
- Onkure Therapeutics, Inc.
- Prosight Management, LP
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Prosight Management, LP · Nov 28, 2025
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026